ANKHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.632390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.968800E-01
Normal-vs-Stage2
1.477840E-01
Normal-vs-Stage3
3.213400E-01
Normal-vs-Stage4
7.032800E-01
Stage1-vs-Stage2
3.550000E-01
Stage1-vs-Stage3
6.022200E-02
Stage1-vs-Stage4
9.582400E-01
Stage2-vs-Stage3
2.458000E-01
Stage2-vs-Stage4
4.134000E-01
Stage3-vs-Stage4
1.266790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.527240E-01
Normal-vs-AfricanAmerican
4.448400E-01
Normal-vs-Asian
4.182800E-01
Caucasian-vs-AfricanAmerican
8.663200E-01
Caucasian-vs-Asian
9.195200E-01
AfricanAmerican-vs-Asian
8.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.177800E-01
Normal-vs-Female
1.326190E-01
Male-vs-Female
3.615000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.454600E-01
Normal-vs-Age(41-60Yrs)
3.450600E-01
Normal-vs-Age(61-80Yrs)
1.317770E-01
Normal-vs-Age(81-100Yrs)
4.445800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.845400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.296600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.635000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.073900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.421750E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.929200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.073600E-01
Normal-vs-Daily Drinker
1.035170E-01
Normal-vs-Weekly Drinker
1.927760E-01
Normal-vs-Occasional Drinker
5.955600E-01
Normal-vs-Social Drinker
2.822800E-01
Non Drinker-vs-Daily Drinker
3.624800E-01
Non Drinker-vs-Weekly Drinker
5.372000E-01
Non Drinker-vs-Occasional Drinker
4.724200E-01
Non Drinker-vs-Social Drinker
6.571200E-01
Daily Drinker-vs-Weekly Drinker
8.956200E-01
Daily Drinker-vs-Occasional Drinker
1.070810E-01
Daily Drinker-vs-Social Drinker
2.075200E-01
Weekly Drinker-vs-Occasional Drinker
2.199800E-01
Weekly Drinker-vs-Social Drinker
3.481400E-01
Occasional Drinker-vs-Social Drinker
8.188800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.746300E-02
Normal-vs-Grade 2
5.038800E-03
Normal-vs-Grade 3
4.158700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.481800E-01
Grade 1-vs-Grade 3
3.438400E-01
Grade 1-vs-Grade 4
4.746300E-02
Grade 2-vs-Grade 3
3.466400E-01
Grade 2-vs-Grade 4
5.038800E-03
Grade 3-vs-Grade 4
4.158700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.732600E-01
Normal-vs-NonDiabetic
1.521410E-01
Diabetic-vs-NonDiabetic
8.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.462600E-01
Normal-vs-NoPancreatitis
1.481830E-01
Pancreatitis-vs-NoPancreatitis
8.324800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.204200E-01
Normal-vs-N1
1.215410E-01
N0-vs-N1
1.909770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.162600E-01
Normal-vs-TP53-NonMutant
4.176800E-01
TP53-Mutant-vs-TP53-NonMutant
8.258600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
